Levocarnitine
Pricing Report NDC 50383-171-04

Latest NADAC: $0.15945 per ML · Effective Jun 21, 2023 · Est. package price $18.82 (118 ML)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

The latest wholesale acquisition cost for Levocarnitine (NDC 50383-171-04) is $0.15945 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jun 21, 2023.

As a provided by Akorn, this medication is distributed in a 118 mL in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.15945
Per ML

Effective Date
Jun 21, 2023
Billable Units
118 ML
Estimated Package Price
$18.82
Data Status
As of Jun 28, 2023
C/I - Chain or Independent Pharmacy
Package NDC
Description
118 mL in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.15177 to $0.89055 per ML. Over this 9 years and 7 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.1518 - $0.8906
Market Volatility
486.78% Variance
Latest Trend
16.72%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Jun 21, 2023 $0.15945 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 17, 2023 $0.19147 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 19, 2023 $0.17660 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 22, 2023 $0.19223 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Feb 22, 2023 $0.18547 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 18, 2023 $0.19571 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 21, 2022 $0.20410 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 23, 2022 $0.22937 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 19, 2022 $0.22797 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 21, 2022 $0.18541 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 17, 2022 $0.22410 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 20, 2022 $0.23012 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026